Clinical Trial Update: Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating Umbilical Cord Blood CD19-BCMA CART Cell Therapy for refractory lupus nephritis, systemic sclerosis, and primary Sjögren's syndrome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome with Pulmonary Arterial Hypertension
• Systemic Lupus Erythematosus with Lupus Nephritis
• Systemic Sclerosis

Drugs mentioned

• Umbilical Cord Blood CD19-BCMA CART Cell Therapy

Snippet

Sponsor: Beijing GoBroad Hospital | Conditions: Refractory Lupus Nephritis, Systemic Sclerosis | Phase 1, Phase 2 | Status: RECRUITING